143 related articles for article (PubMed ID: 37667188)
1. Analysis of differentially expressed genes discovers Latroeggtoxin VI-induced changes and SYNJ1 as a main target in PC12 cells.
Yu D; Wang H; Lei Z; Zhai Y; Chen S; Sun M; Yin P; Wang X
BMC Genomics; 2023 Sep; 24(1):517. PubMed ID: 37667188
[TBL] [Abstract][Full Text] [Related]
2. Pull-Down Assay-Guided Insights into the Effects of Latroeggtoxin-VI on Nerve Cells.
Tang X; Yu D; Wang H; Meng W; Zhai Y; Lei Z; Liu Z; Wang X
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673184
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and cytotoxic evaluation of latroeggtoxin-VI against PC12 cells.
Tang X; Yu D; Wang H; Meng W; Lei Z; Zhai Y; Wang Y; Wang X
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22825. PubMed ID: 34047418
[TBL] [Abstract][Full Text] [Related]
4. Synaptotagmin 1-mediated cell membrane penetration and dopamine release enhancement by latroeggtoxin-VI.
Tang X; Yu D; Wang H; Lei Z; Zhai Y; Sun M; Chen S; Wang Y; Liu Z; Hu W; Wang X
Int J Biol Macromol; 2022 Sep; 216():906-915. PubMed ID: 35914553
[TBL] [Abstract][Full Text] [Related]
5. Insights into the mediation of Ca
Lei Z; Wang H; Zhai Y; Sun M; Chen S; Yin P; Wang X
J Cell Commun Signal; 2023 Dec; 17(4):1309-1321. PubMed ID: 37702818
[TBL] [Abstract][Full Text] [Related]
6. Latroeggtoxin-VI protects nerve cells and prevents depression by inhibiting NF-κB signaling pathway activation and excessive inflammation.
Wang H; Zhai Y; Lei Z; Chen S; Sun M; Yin P; Duan Z; Wang X
Front Immunol; 2023; 14():1171351. PubMed ID: 37256144
[TBL] [Abstract][Full Text] [Related]
7. [Gene cloning, heterologous expression and activity identification of latroeggtoxin-Ⅵ].
Yan S; Tang X; Yu D; Wang H; Meng W; Tang P; Wang X
Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):635-645. PubMed ID: 33645161
[TBL] [Abstract][Full Text] [Related]
8. Anti-Breast Cancer Activity of Latroeggtoxin-V Mined from the Transcriptome of Spider
Xu D; Tang X; Wu X; Yu D; Tang P; Wang X
Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30400202
[TBL] [Abstract][Full Text] [Related]
9. Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model.
Zhu L; Zhong M; Zhao J; Rhee H; Caesar I; Knight EM; Volpicelli-Daley L; Bustos V; Netzer W; Liu L; Lucast L; Ehrlich ME; Robakis NK; Gandy SE; Cai D
J Biol Chem; 2013 Nov; 288(44):32050-63. PubMed ID: 24052255
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein overexpression induced mitochondrial damage by the generation of endogenous neurotoxins in PC12 cells.
Zhang Y; Ma H; Xie B; Han C; Wang C; Qing H; Deng Y
Neurosci Lett; 2013 Jun; 547():65-9. PubMed ID: 23680459
[TBL] [Abstract][Full Text] [Related]
11. IA-2 modulates dopamine secretion in PC12 cells.
Nishimura T; Harashima S; Yafang H; Notkins AL
Mol Cell Endocrinol; 2010 Feb; 315(1-2):81-6. PubMed ID: 19799965
[TBL] [Abstract][Full Text] [Related]
12. Isolation and preliminary characterization of proteinaceous toxins with insecticidal and antibacterial activities from black widow spider (L. tredecimguttatus) eggs.
Lei Q; Yu H; Peng X; Yan S; Wang J; Yan Y; Wang X
Toxins (Basel); 2015 Mar; 7(3):886-99. PubMed ID: 25785465
[TBL] [Abstract][Full Text] [Related]
13. Rab3A Inhibition of Ca
Dai Z; Tang X; Chen J; Tang X; Wang X
J Cell Biochem; 2017 Nov; 118(11):3696-3705. PubMed ID: 28370453
[TBL] [Abstract][Full Text] [Related]
14. The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer's disease.
Ando K; Ndjim M; Turbant S; Fontaine G; Pregoni G; Dauphinot L; Yilmaz Z; Suain V; Mansour S; Authelet M; De Dekker R; Leroy K; Delatour B; ; Duyckaerts C; Potier MC; Brion JP
Acta Neuropathol Commun; 2020 Jun; 8(1):79. PubMed ID: 32493451
[TBL] [Abstract][Full Text] [Related]
15. Expression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteins.
So CW; Sham MH; Chew SL; Cheung N; So CK; Chung SK; Caldas C; Wiedemann LM; Chan LC
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):447-58. PubMed ID: 10816441
[TBL] [Abstract][Full Text] [Related]
16. Screening assay for small-molecule inhibitors of synaptojanin 1, a synaptic phosphoinositide phosphatase.
McIntire LB; Lee KI; Chang-Ileto B; Di Paolo G; Kim TW
J Biomol Screen; 2014 Apr; 19(4):585-94. PubMed ID: 24186361
[TBL] [Abstract][Full Text] [Related]
17. Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease.
McIntire LB; Berman DE; Myaeng J; Staniszewski A; Arancio O; Di Paolo G; Kim TW
J Neurosci; 2012 Oct; 32(44):15271-6. PubMed ID: 23115165
[TBL] [Abstract][Full Text] [Related]
18. Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.
Liu YY; Yang XY; Li Z; Liu ZL; Cheng D; Wang Y; Wen XJ; Hu JY; Liu J; Wang LM; Wang HJ
CNS Neurosci Ther; 2014 Jan; 20(1):76-85. PubMed ID: 24279586
[TBL] [Abstract][Full Text] [Related]
19. Mini-review: Synaptojanin 1 and its implications in membrane trafficking.
Choudhry H; Aggarwal M; Pan PY
Neurosci Lett; 2021 Nov; 765():136288. PubMed ID: 34637856
[TBL] [Abstract][Full Text] [Related]
20. Chorein Sensitive Dopamine Release from Pheochromocytoma (PC12) Cells.
Honisch S; Fehrenbacher B; Lebedeva A; Alesutan I; Castor T; Alkahtani S; Alarifi S; Schaller M; Stournaras C; Lang F
Neurosignals; 2015; 23(1):1-10. PubMed ID: 26656295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
